ADMP - Adamis Pharmaceuticals Corporation Stock Price, Fair Value and News

Market Closed

ADMP Stock Price

View Fullscreen

ADMP RSI Chart

ADMP Valuation

Market Cap

8.0M

Price/Earnings (Trailing)

-0.36

Price/Sales (Trailing)

2.21

EV/EBITDA

-0.05

Price/Free Cashflow

-0.85

ADMP Price/Sales (Trailing)

ADMP Profitability

EBT Margin

-723.75%

Return on Equity

-6.99%

Return on Assets

-248.2%

Free Cashflow Yield

-117.33%

ADMP Fundamentals

ADMP Revenue

Revenue (TTM)

3.6M

ADMP Earnings

Earnings (TTM)

-22.2M

Breaking Down ADMP Revenue

How does ADMP drawdown profile look like?

ADMP Financial Health

Current Ratio

0.58

ADMP Investor Care

Shares Dilution (1Y)

371.48%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	5.1M	5.1M	3.6M	0
2022	2.9M	3.5M	4.2M	4.9M
2021	6.9M	4.2M	4.1M	2.2M
2020	21.9M	20.0M	15.0M	10.1M
2019	16.8M	18.7M	20.7M	22.1M
2018	13.2M	13.3M	13.8M	15.1M
2017	8.1M	9.8M	11.4M	13.1M
2016	0	0	0	6.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation Frequently Asked Questions

What is the ticker symbol for Adamis Pharmaceuticals Corporation? What does ADMP stand for in stocks?

ADMP is the stock ticker symbol of Adamis Pharmaceuticals Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Adamis Pharmaceuticals Corporation (ADMP)?

As of Tue Oct 31 2023, market cap of Adamis Pharmaceuticals Corporation is 7.99 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ADMP stock?

You can check ADMP's fair value in chart for subscribers.

Is Adamis Pharmaceuticals Corporation a good stock to buy?

The fair value guage provides a quick view whether ADMP is over valued or under valued. Whether Adamis Pharmaceuticals Corporation is cheap or expensive depends on the assumptions which impact Adamis Pharmaceuticals Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ADMP.

What is Adamis Pharmaceuticals Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Oct 31 2023, ADMP's PE ratio (Price to Earnings) is -0.36 and Price to Sales (PS) ratio is 2.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ADMP PE ratio will change depending on the future growth rate expectations of investors.